Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 8Neoplasm Metastasis 8Carcinoma, Non-Small-Cell Lung 8Breast Neoplasms 8Colorectal Neoplasms 7Prostatic Neoplasms 6Urinary Bladder Neoplasms 5Leukemia, Myeloid, Acute 5Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Lung Neoplasms 4Glioblastoma 4Triple Negative Breast Neoplasms 3Mouth Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Ureteral Neoplasms 2Stomatitis 2Recurrence 2Oropharyngeal Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Gastrointestinal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma 2COVID-19 2Brain Neoplasms 2Adenocarcinoma 2

Interventions

Gemcitabine 26Capecitabine 16Oxaliplatin 14Fluorouracil 13Cisplatin 12Leucovorin 9pembrolizumab 5Erlotinib Hydrochloride 5Bevacizumab 5durvalumab 4Trastuzumab 4Specimen Handling 4Sorafenib 4Magnetic Resonance Spectroscopy 4130-nm albumin-bound paclitaxel 4trifluridine tipiracil drug combination 3Lapatinib 3Irinotecan 3Carboplatin 3Biopsy 3tremelimumab 2toripalimab 2regorafenib 2lenvatinib 2dehydroftorafur 2cobimetinib 2atezolizumab 2anlotinib 2Nivolumab 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Gallbladder Neoplasms × Standard of Care × Clear all
NCT04362449 2022-07-15

Comparing the Current Hydration Regimen for the ABC02 Chemotherapy Regimen Versus a Shorter Hydration

Imperial College Healthcare NHS Trust

Phase 2 Unknown
30 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡